Chargement en cours...
Current and Emerging Therapy for Malignant Pleural Mesothelioma: Focus on CD26/Dipeptidyl Peptidase IV as a Therapeutic Target
BACKGROUND: Malignant mesothelioma is a largely incurable disease that is refractory to current therapies. CD26 is a multifunctional cell surface protein involved in autoimmune disease, diabetes, and cancer. It has a role in T cell function, extracellu-lar protein modification, as a prognostic facto...
Enregistré dans:
| Publié dans: | Curr Med Chem |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Bentham Science Publishers
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5737002/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1573394713666170907160734 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|